Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of FX006 (Zilretta) in Hip Osteoarthritis
NCT03793010Phase 3Terminated
- Sponsor
- Pacira BioSciences
- Start
- Dec 2018
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in osteoarthritis (OA), sponsored by Pacira BioSciences. Started Dec 2018; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03793010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03793010.